 | TG Therapeutics, Inc. | |||
| NCM : TGTX || Location: United States | ||||
$13.47-0.44 (-3.16%) |
2.84 M | 13.41 - 14.01 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 35.711 M |
| March 28, 2024 | 34.355 M |
| March 15, 2024 | 34.185 M |
| Feb. 29, 2024 | 34.841 M |
| Feb. 15, 2024 | 35.777 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.11 | -0.10 | 6.01% |
| 09/30/2023 | 0.12 | 0.73 | 518.64% |
| 06/30/2023 | -0.25 | -0.34 | -34.02% |
| 03/31/2023 | -0.37 | -0.28 | 25.23% |
| 12/31/2022 | -0.27 | -0.39 | -47.06% |
TGTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 154.421M | Shares Float | 135.508M |
| Short Float | 35.711M | Market Cap | 2148.00M |
| Institution ownership | 59.28% | Insider ownership | 9.077% |
| Earnings Date | 04/29/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 0.09 | Forward EPS | 0.53 |